Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin – A real world experience https://doi.org/10.1101/2020.08.05.20151027 This is a retrospective observational study to assess the effect of HCQ and Azithromycin on duration from symptom onset to… Continue reading "(11 Aug 2020) Hydroxychloroquine and Azithromycin-delayed SARS-CoV-2 virus clearance"
Clinical outcomes and adverse events in patients hospitalised with COVID ‐19, treated with off‐ label hydroxychloroquine and azithromycin https://doi.org/10.1111/bcp.14482 In a retrospective analysis of hospitalised patients that had a positive polymerase chain reaction (PCR) test for SARS-CoV-2 and received hydroxychloroquine… Continue reading "(22 July 2020) Hydroxychloroquine- No clinical improvement observed"
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 https://doi.org/10.1016/j.ijid.2020.06.099 Of 2,541 patients, with a median total hospitalization time of 6 days (IQR: 4-10 days), median age was 64 years (IQR:53-76 years), 51% male, 56% African American, with… Continue reading "(06 July 2020) Hydroxychloroquine- use of hydroxychloroquine alone and in combination with azithromycin was associated with significant reduction in-hospital mortality"
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State https://jamanetwork.com/journals/jama/fullarticle/2766117 Among 1438 hospitalized patients with a diagnosis of COVID-19 (858 [59.7%] male, median age, 63 years), those receiving hydroxychloroquine, azithromycin, or… Continue reading "(11 May 2020) Hydroxychloroquine- not significantly associated with differences in in-hospital mortality"
